Human anti-idiotypic antibody fragments that mimic HER-2/neu
US7892542B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 14, 2004 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Apr 26, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to human anti-idiotypic antibody fragments, especially scFv, characterized by the ability to mimic Her-2/neu tumor associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients positive for Her-2/neu.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.